Area of research
Immunology · Oncology
Research interest
Research interests include Immunotherapy and Immune Responses, interferon and immune responses, Cancer Immunotherapy and Biomarkers, and Nanoplatforms for cancer theranostics.
Prolonged activation of innate immune pathways by a polyvalent STING agonist
Mitomycin C enhanced the efficacy of PD-L1 blockade in non-small cell lung cancer
A STING-activating nanovaccine for cancer immunotherapy
Synthetic nanovaccines for immunotherapy
Innate Immune Activation by cGMP-AMP Nanoparticles Leads to Potent and Long-Acting Antiretroviral Response against HIV-1